国际皮肤性病学杂志    0  (): 285-287   ISSN: 2096-5540  CN: 32-1880/R   天然免疫紊乱与银屑病 管海宏, 刘玉峰, 沈柱 第四军医大学附属西京医院皮肤科, 西安710032 收稿日期 2004-12-07  修回日期 null  网络版发布日期 null 参考文献  [1] Andressen C, Henseler T. Inheritance of psoriasis. Analysis of 2035family histories. Hautarzt, 1982, 33:214-217. [2] Borregaard N, Elsbach P, Ganz T,et al. Innate immunity:from plants to humans. Immunol Today, 2000, 21:68-70. [3] Takeda K, Akira S. Toll-like receptors in innate immunity. Int Immunol, 2005, 17:1-14. [4] Fearon DT, Locksley RM. The instructive role of innate immunity in the acquired immune response. Science, 1996, 272:50-53. [5] Cameron AL, Kirby B, Griffiths CE. Circulating natural killer cells in psoriasis. Br J Dermatol, 2003, 149:160-164. [6] Koreck A, Suranyi A, Szony BJ, et al. CD3:CD56:NK T cells are significantly decreased in the peripheral blood of patients with psoriasis. Clin Exp Immunol, 2002, 127:176-182. [7] Chan WL, Pejnovic N, Liew TV, et al. NKT cell subsets in infection and inflammation. Immunol Lett, 2003, 85:159-163. [8] Curry JL, Qin JZ, Bonish B, et al. Innate immune-related receptors in normal and psoriatic skin. Arch Pathol Lab Med, 2003, 127:178-186. [9] Siegel I, Liu TL, Gleicher N. The red-cell immune system. Lancet,1981, 2:556-559. [10] Rocha-Pereira P, Santos-Silva A, Rebelo Ⅰ, et al. Erythrocyte damage in mild and severe psoriasis. Br J Dermatol, 2004, 150:232-244. [11] Gornicki A, Gutsze A. Erythrocyte membrane fluidity changes in psoriasis:an EPR study. J Dermatol Sci, 2001, 27:27-30. [12] Triolo G, Accardo-Palumbo A, Salli L, et al. Impaired expression of erythrocyte glycosyl-phosphatidylinositol-anchored membrane CD59 in patients with psoriatic arthritis. Relation to terminal complement pathway activation. Clin Exp Rheumatol, 2003, 21:225-228. [13] Ozturk G, Erbas D, Gelir E, et al. Natural killer cell activity, serum immunoglobulins, complement proteins, and zinc levels in patients with psoriasis vulgaris. Immunol Invest, 2001, 30:181-190. [14] Gasior-Chrzan B, Falk ES. Lysozyme and IgA concentrations in serum and saliva from psoriatic patients. Acta Derm Venereol,1992,72:138-140. [15] Li CX, Wan YH, Chi SM, et al. Purification of natural antikeratin autoantibodies from normal human serum and their effect on human keratinocytes cultured in vitro. Br J Dermatol, 2001, 145:737-748. [16] Kirby B, Griffiths CE. Novel imrmune-based therapies for psoriasis.Br J Dermatol, 2002, 146:546-551. 通讯作者: